SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001047469-18-007270
Filing Date
2018-11-16
Accepted
2018-11-16 06:18:51
Documents
8
Effectiveness Date
2018-11-16

Document Format Files

Seq Description Document Type Size
1 DEFM14A a2237105zdefm14a.htm DEFM14A 1432375
3 G371632BKI001.GIF g371632bki001.gif GRAPHIC 140524
4 G371632BKI002.GIF g371632bki002.gif GRAPHIC 76744
5 G371634CAI001.JPG g371634cai001.jpg GRAPHIC 7886
6 G794188.JPG g794188.jpg GRAPHIC 4091
7 G627228.JPG g627228.jpg GRAPHIC 5571
8 G72350.JPG g72350.jpg GRAPHIC 5229
9 G908249.JPG g908249.jpg GRAPHIC 12781
  Complete submission text file 0001047469-18-007270.txt   1782429
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35050 | Film No.: 181188634
SIC: 2834 Pharmaceutical Preparations